| Mrs Joyce Keiko Takazono Canute, MS, CCC-SLP | |
|
45-691 Keaahala Rd, Room 30, Kaneohe, HI 96744-3569 | |
| (808) 233-5494 | |
| Not Available |
| Full Name | Mrs Joyce Keiko Takazono Canute |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 45-691 Keaahala Rd, Kaneohe, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134311285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-557 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Joyce Keiko Takazono Canute, MS, CCC-SLP 47-189 Hui Akepa Pl, Unit A, Kaneohe, HI 96744-4384 Ph: (808) 239-5897 | Mrs Joyce Keiko Takazono Canute, MS, CCC-SLP 45-691 Keaahala Rd, Room 30, Kaneohe, HI 96744-3569 Ph: (808) 233-5494 |
News Archive
Mayo Clinic researchers in collaboration with scientists at Perlegen Sciences, Inc. and funded by the Michael J. Fox Foundation for Parkinson's Research have produced the first large-scale whole genome map of genetic variability associated with Parkinson's disease.
Winston Pharmaceuticals, Inc. a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study on its patented Dolorac Nasal Solution (doxepin 0.4%) for prophylaxis of chronic migraine at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.
Researchers at Karolinska Institutet present a publicly available resource that can accelerate the use of so-called FISH techniques for studying how the genome is spatially organised in the cell nucleus.
BioLineRx, a biopharmaceutical drug development company, and Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that they have signed a worldwide, exclusive license agreement for BioLineRx to develop and commercialize BL-7040, an orally available Phase II ready molecule for treating Inflammatory Bowel Disease (IBD) and other inflammatory diseases.
› Verified 9 days ago
Kelli Takushi-geyrozaga, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 47-794 Ahuimanu Rd, Kaneohe, HI 96744 Phone: 650-218-9681 | |
Keiki Communication Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45-727 Puupele St, Kaneohe, HI 96744 Phone: 808-352-0177 | |
Kristie Kido, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45-691 Keaahala Rd, Room 30, Kaneohe, HI 96744 Phone: 808-233-5495 Fax: 808-233-5494 | |
Charlotte Ann Freeman, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45014a Waikalua Road, Kaneohe, HI 96744 Phone: 808-352-4805 | |
Megan Noelani Fienhold, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45-727 Puupele St, Kaneohe, HI 96744 Phone: 808-352-0177 | |
Anna Kathryn Kolacz, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 46-169 Kamehameha Hwy, Kaneohe, HI 96744 Phone: 808-233-5700 |